HYBRIMS aims at the development and viability of a Knowledge-Based Company (EBC) created from the development of a patented medical technology that combines gamma and ultrasound imaging with the ability to guide real-time cancer biopsy. This innovative device adds the metabolic information provided by gamma images, which visualize the most active or aggressive areas of the tumor, to the morphological information obtained with ultrasounds, providing the specialist with more precise tumor information.
.png)
